
MxT Biotech is a pioneering biotechnology company,
and the inventor of the Hydroporator®, the next-generation non-viral gene delivery platform.
Our cutting-edge technology provides a critical solution for CGT researchers, developers, and
manufacturers, empowering them to achieve breakthroughs with greater efficiency.
By delivering this core bioengineering innovation, MxT Biotech plays a vital role in supporting
CGT companies and research institutions, driving transformative progress in the life science field.